Walgreens Boots Alliance (NASDAQ:WBA) issued its earnings results on Wednesday. The pharmacy operator reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.19, MarketWatch Earnings reports. The company had revenue of $36.31 billion for the quarter, compared to analyst estimates of $35.01 billion. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.37 earnings per share.
Shares of WBA traded up $0.76 during midday trading on Friday, hitting $46.02. The company had a trading volume of 253,435 shares, compared to its average volume of 11,145,039. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 0.58. The company’s 50 day moving average price is $40.18 and its 200 day moving average price is $39.23. The stock has a market cap of $39.76 billion, a price-to-earnings ratio of 91.50, a PEG ratio of 1.52 and a beta of 0.44. Walgreens Boots Alliance has a 52 week low of $33.36 and a 52 week high of $56.80.
The company also recently announced a quarterly dividend, which was paid on Friday, December 11th. Shareholders of record on Thursday, November 19th were paid a $0.4675 dividend. The ex-dividend date was Wednesday, November 18th. This represents a $1.87 annualized dividend and a yield of 4.06%. Walgreens Boots Alliance’s payout ratio is currently 39.45%.
In related news, CAO Marco Patrick Anthony Pagni sold 5,000 shares of the company’s stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $41.55, for a total transaction of $207,750.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 16.91% of the stock is owned by corporate insiders.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Further Reading: How is a Moving Average Calculated?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.